Development of risk groups in metastatic castration-resistant prostate cancer (mCRPC) to facilitate the identification of active chemotherapy regimens
Publication
, Conference
Armstrong, AJ; Halabi, S; Tannock, IF; George, DJ; Dewit, R; Eisenberger, M
Published in: JOURNAL OF CLINICAL ONCOLOGY
May 20, 2009
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
ISSN
0732-183X
Publication Date
May 20, 2009
Volume
27
Issue
15
Location
Orlando, FL
Publisher
AMER SOC CLINICAL ONCOLOGY
Conference Name
45th Annual Meeting of the American-Society-of-Clinical-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Armstrong, A. J., Halabi, S., Tannock, I. F., George, D. J., Dewit, R., & Eisenberger, M. (2009). Development of risk groups in metastatic castration-resistant prostate cancer (mCRPC) to facilitate the identification of active chemotherapy regimens. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 27). Orlando, FL: AMER SOC CLINICAL ONCOLOGY.
Armstrong, A. J., S. Halabi, I. F. Tannock, D. J. George, R. Dewit, and M. Eisenberger. “Development of risk groups in metastatic castration-resistant prostate cancer (mCRPC) to facilitate the identification of active chemotherapy regimens.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 27. AMER SOC CLINICAL ONCOLOGY, 2009.
Armstrong AJ, Halabi S, Tannock IF, George DJ, Dewit R, Eisenberger M. Development of risk groups in metastatic castration-resistant prostate cancer (mCRPC) to facilitate the identification of active chemotherapy regimens. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2009.
Armstrong, A. J., et al. “Development of risk groups in metastatic castration-resistant prostate cancer (mCRPC) to facilitate the identification of active chemotherapy regimens.” JOURNAL OF CLINICAL ONCOLOGY, vol. 27, no. 15, AMER SOC CLINICAL ONCOLOGY, 2009.
Armstrong AJ, Halabi S, Tannock IF, George DJ, Dewit R, Eisenberger M. Development of risk groups in metastatic castration-resistant prostate cancer (mCRPC) to facilitate the identification of active chemotherapy regimens. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2009.
Published In
JOURNAL OF CLINICAL ONCOLOGY
ISSN
0732-183X
Publication Date
May 20, 2009
Volume
27
Issue
15
Location
Orlando, FL
Publisher
AMER SOC CLINICAL ONCOLOGY
Conference Name
45th Annual Meeting of the American-Society-of-Clinical-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences